Can we trust vaccine recommendations when pharmaceutical companies make money from vaccines? It’s a fair question—and one that deserves more than simply being told to trust the system.

In Episode 5 of Deep Dives, we follow the money: how vaccine economics actually work, where pharmaceutical incentives and conflicts of interest exist, and what safeguards are designed to separate financial interests from vaccine recommendations.

We’ll also talk about where skepticism is justified, where some common assumptions don’t match the evidence, and why transparency—not pretending conflicts don’t exist—is essential to rebuilding trust.

What exactly is in a vaccine—and should we be worried about it? In this episode of Deep Dives, we take a closer look at mercury, aluminum, formaldehyde, and preservatives: why they’ve been used, how much is actually present, what happens to them in the body, and what the evidence tells us about their safety.

Episode 3: Too Many, Too Soon?

Are kids getting too many vaccines too early? In this episode of Deep Dives, we take that concern seriously and look at why the modern vaccine schedule can feel overwhelming, how much antigen exposure children actually receive, and what we know about the immune system’s ability to handle it.

We’ll also dig into the evidence comparing children vaccinated on schedule with those who receive vaccines later, and talk about the often-overlooked tradeoffs of delaying. No dismissing the question—just a closer look at what the science actually tells us.